Evaluation of Bevacizumab (Avastin) Therapy for Diabetic Macular Edema
Tarek Mohamed Abdel Aziz;
Abstract
Diabetic macular edema is a well-documented, sight threatening complication of diabetes mellitus. DME is the most common cause of visual impairment in patients with diabetes.
The pathogenesis of DME could be studied on the basis of changes in the blood-re
The pathogenesis of DME could be studied on the basis of changes in the blood-re
Other data
| Title | Evaluation of Bevacizumab (Avastin) Therapy for Diabetic Macular Edema | Authors | Tarek Mohamed Abdel Aziz | Keywords | Evaluation of Bevacizumab (Avastin) Therapy for Diabetic Macular Edema | Issue Date | 2009 | Description | Diabetic macular edema is a well-documented, sight threatening complication of diabetes mellitus. DME is the most common cause of visual impairment in patients with diabetes. The pathogenesis of DME could be studied on the basis of changes in the blood-re |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.